CRISPR Therapeutics AG (NASDAQ: CRSP) on Friday, plunged -3.88% from the previous trading day, before settling in for the closing price of $41.29. Within the
A new trading day began on Monday, with CRISPR Therapeutics AG (NASDAQ: CRSP) stock price up 3.44% from the previous day of trading, before settling
CRISPR Therapeutics AG (NASDAQ: CRSP) open the trading on Thursday, with great promise as it jumped 5.26% to $41.43, before settling in for the price
A new trading day began on Monday, with CRISPR Therapeutics AG (NASDAQ: CRSP) stock price down -3.42% from the previous day of trading, before settling
CRISPR Therapeutics AG (NASDAQ: CRSP) open the trading on Thursday, with great promise as it jumped 0.32% to $41.07, before settling in for the price
CRISPR Therapeutics AG (NASDAQ: CRSP) kicked off on Tuesday, up 0.88% from the previous trading day, before settling in for the closing price of $44.24.
CRISPR Therapeutics AG (NASDAQ: CRSP) started the day on Thursday, with a price decrease of -4.98% at $45.40, before settling in for the price of
On Monday, CRISPR Therapeutics AG (NASDAQ: CRSP) was -4.76% drop from the session before settling in for the closing price of $52.33. A 52-week range
Witnessing the stock’s movement on the chart, on Thursday, CRISPR Therapeutics AG (NASDAQ: CRSP) had a quiet start as it plunged -3.19% to $49.51, before
On Monday, CRISPR Therapeutics AG (NASDAQ: CRSP) was 7.78% up from the session before settling in for the closing price of $51.17. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
